News
-
-
-
COMMUNIQUÉ DE PRESSE
Biomind Labs Applauds Landmark Executive Order Accelerating Psychedelic Research and Access in The United States
President Trump signs executive order to fast-track research and patient access to psychedelic therapies, aligning with Biomind's mission to transform neuropsychiatric care -
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Biomind Labs Accelerates FDA Pathway for 5-MEO-DMT Candidate BMND08 with Proprietary Nano-Formulation as Patent Observations Are Successfully Withstood
Biomind Labs advances BMND08 into FDA-directed activities with newly engineered nano-formulation drug-delivery platform, strengthening patent position -